ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*assay methods#organism*Homo sapiens#literature*486979#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*assay methods#organism*Homo sapiens#literature*486980#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*assay methods#organism*Homo sapiens#literature*486993#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*486996#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*486997#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*486998#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*487000#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*487002#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*487003#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*487007#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*487008#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*acyltransferase and esterase activities of several truncated recombinant enzymes#organism*Homo sapiens#literature*487013#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*patients with Alzheimer's disease have lower LCAT activity in cerebrospinal fluid#organism*Homo sapiens#literature*487018#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*LCAT activity for several phosphatidylcholine analogs with different chain insaturation#organism*Homo sapiens#literature*487021#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*recombinant enzyme is half as enzymatically active as plasma LCAT#organism*Homo sapiens#literature*487024#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*activity of the wild-type and two naturally occurring mutant enzymes#organism*Homo sapiens#literature*487027#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*cholesterol esterification and phospholipase A2 activities of wild-type and mutant enzymes with different substrates, overview#organism*Homo sapiens#literature*661064#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*661106#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*activity with 80 and 93 A HDL particles, and with wild-type and different mutant of apolipoprotein A-I, overview#organism*Homo sapiens#literature*661198#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*activities produced by different lung cell clones expressing the enzyme#organism*Homo sapiens#literature*663302#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*671676#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*lipid accumulation in wild-type and LCAT-/- mutant strains, overview#organism*Mus musculus#literature*675258#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*LCAT activity in parallel with HDL2 and HDL3 amounts and composition in pregnancy induced hypertension and chronic hypertensive mothers and in their small newborns, overview#organism*Homo sapiens#literature*686547#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*diabetic pregnant rats, Isio-4-fed, show a significant reduction of serum LCAT activity compared to control rats. Isio-4-fed macrosomic pups present a significant increase in serum LCAT activity compared to controls. EPAX diet significantly increases LCAT activity in diabetic dams, whlie it induces a decrease in this activity in macrosomic pups#organism*Rattus norvegicus#literature*686933#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*activity of LCAT in men with cardiovascular disease, CVD, compared to healthy men, overview. Plasma LCAT activity is 5% higher in CVD cases in association with higher total cholesterol, non-HDL cholesterol and triglycerides, re-adjusted incident CVD is increased with higher LCAT activity, overview#organism*Homo sapiens#literature*701993#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*LCAT activity in plasma#organism*Homo sapiens#literature*702466#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*plasma LCAT activities in dogs fed with diets differing in starch type or low-glycemic index, and oil type or triacylglycerol, overview#organism*Canis lupus familiaris#literature*705467#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*enzyme activity in plasma from healthy buffaloes, and from buffaloes suffering ketosis or haemoglobinuria, overview#organism*Bubalus bubalis#literature*706707#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*serine palmitoyltransferase deficient mice, and sphingomyelin synthase deficient mice, both of which have below normal sphingomyelin (SM)/phosphatidylcholine (PC) ratios, show significantly elevated LCAT activities when assayed with the endogenous substrates. LDL receptor knockout mice, and apo E knockout mice, both of which have high SM/PC ratios, have reduced LCAT activities#organism*Mus musculus#literature*718994#!ecNumber*2.3.1.43#specificActivity*-999#specificActivityMaximum*#commentary*enzyme activities with apolipoprotein A-I and Apo AI-derived peptides DRV, KLL, and VLES, overview#organism*Homo sapiens#literature*735598#!ecNumber*2.3.1.43#specificActivity*0.00078#specificActivityMaximum*#commentary*purified recombinant enzyme, pH 7.5, 37&Acirc;&deg;C#organism*Toxoplasma gondii#literature*736505#!ecNumber*2.3.1.43#specificActivity*0.001#specificActivityMaximum*#commentary*recombinant enzyme#organism*Homo sapiens#literature*487025#!ecNumber*2.3.1.43#specificActivity*0.01#specificActivityMaximum*#commentary*in cholesterol-lecithin vesicles activated with apolipoprotein A1, at 37&Acirc;&deg;C and pH 7.1#organism*Homo sapiens#literature*487007#!ecNumber*2.3.1.43#specificActivity*0.06#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*487002#!ecNumber*2.3.1.43#specificActivity*0.08#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*487003#!ecNumber*2.3.1.43#specificActivity*0.14#specificActivityMaximum*#commentary*in cholesterol-lecithin vesicles activated with rat apolipoprotein A1#organism*Rattus norvegicus#literature*487005#!ecNumber*2.3.1.43#specificActivity*0.15#specificActivityMaximum*#commentary*in cholesterol-lecithin vesicles activated with porcine apolipoprotein A1#organism*Sus scrofa#literature*486989#!ecNumber*2.3.1.43#specificActivity*0.217#specificActivityMaximum*#commentary*purified recombinant enzyme, pH 7.4, 37&Acirc;&deg;C, substrates are 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine and dehydroergosterol#organism*Homo sapiens#literature*735428#!ecNumber*2.3.1.43#specificActivity*0.27#specificActivityMaximum*#commentary*in cholesterol-lecithin vesicles activated with apolipoprotein A1#organism*Homo sapiens#literature*486992#!ecNumber*2.3.1.43#specificActivity*0.34#specificActivityMaximum*#commentary*at 37&Acirc;&deg;C in cholesterol-lecithin vesicles#organism*Homo sapiens#literature*486990#!ecNumber*2.3.1.43#specificActivity*0.402#specificActivityMaximum*#commentary*purified recombinant enzyme, substrate cholesterol#organism*Homo sapiens#literature*662168#!ecNumber*2.3.1.43#specificActivity*0.42#specificActivityMaximum*#commentary*purified recombinant enzyme, substrate sitosterol#organism*Homo sapiens#literature*662168#!ecNumber*2.3.1.43#specificActivity*0.43#specificActivityMaximum*#commentary*recombinant C-terminal histidine tagged enzyme, similar to plasma enzyme#organism*Homo sapiens#literature*487023#!ecNumber*2.3.1.43#specificActivity*0.47#specificActivityMaximum*#commentary*HDL substrate at 37&Acirc;&deg;C#organism*Sus scrofa#literature*486991#!ecNumber*2.3.1.43#specificActivity*0.54#specificActivityMaximum*#commentary*at 37&Acirc;&deg;C and pH: 7.4#organism*Homo sapiens#literature*486981#!ecNumber*2.3.1.43#specificActivity*0.55#specificActivityMaximum*#commentary*in cholesterol-lecithin vesicles activated with human apolipoprotein A1#organism*Capra hircus#literature*486995#!ecNumber*2.3.1.43#specificActivity*0.56#specificActivityMaximum*#commentary*in cholesterol-lecithin vesicles activated with human apolipoprotein A1#organism*Oryctolagus cuniculus#literature*486995#!ecNumber*2.3.1.43#specificActivity*0.57#specificActivityMaximum*#commentary*in cholesterol-lecithin vesicles activated with apolipoprotein A1#organism*Canis lupus familiaris#literature*486995#!ecNumber*2.3.1.43#specificActivity*0.57#specificActivityMaximum*#commentary*in cholesterol-lecithin vesicles activated with apolipoprotein A1#organism*Homo sapiens#literature*486995#!ecNumber*2.3.1.43#specificActivity*0.59#specificActivityMaximum*#commentary*in cholesterol-lecithin vesicles activated with human apolipoprotein A1#organism*Sus scrofa#literature*486995#!ecNumber*2.3.1.43#specificActivity*0.867#specificActivityMaximum*#commentary*purified recombinant enzyme, pH 7.4, 37&Acirc;&deg;C, substrates are 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine and cholesterol#organism*Homo sapiens#literature*735428#!ecNumber*2.3.1.43#specificActivity*2.7#specificActivityMaximum*#commentary*in cholesterol-lecithin vesicles#organism*Homo sapiens#literature*486978#!ecNumber*2.3.1.43#specificActivity*3.47#specificActivityMaximum*#commentary*in cholesterol-lecithin vesicles activated with apolipoprotein A1#organism*Homo sapiens#literature*486998#!ecNumber*2.3.1.43#specificActivity*53#specificActivityMaximum*#commentary*in cholesterol-lecithin vesicles activated with apolipoprotein A1#organism*Homo sapiens#literature*486980#!ecNumber*2.3.1.43#specificActivity*137#specificActivityMaximum*#commentary*in cholesterol-lecithin vesicles#organism*Aeromonas salmonicida#literature*486977#